Table 1.
Experiment | Con | ETA + Bi | NOSi | NOSi/ETA + Bi | PDE5i | ROSi |
---|---|---|---|---|---|---|
Con |
Diseased 12 Healthy 11 |
Healthy 6 | Healthy 7 | Healthy 5 | Healthy 6 | Healthy 8 |
ETA + Bi | Diseased 6 |
Diseased 6 Healthy 6 |
Healthy 4 | Healthy 5 | Healthy 6 | Healthy 5 |
NOSi | Diseased 6 | Diseased 4 |
Diseased 6 Healthy 7 |
Healthy 5 | Healthy 5 | Healthy 4 |
NOSi/ETA+Bi | Diseased 4 | Diseased 4 | Diseased 3 |
Diseased 4 Healthy 6 |
Healthy 6 | Healthy 6 |
PDE5i | Diseased 7 | Diseased 4 | Diseased 3 | Diseased 3 |
Diseased 7 Healthy 7 |
Healthy 6 |
ROSi | Diseased 8 | Diseased 5 | Diseased 6 | Diseased 3 | Diseased 4 |
Diseased 8 Healthy 8 |
Numbers in bold denote the total numbers in a protocol, diseased reflect animal with DM + HC + CKD
Con control exercise experiment without pharmacological intervention, NOSi nitric oxide inhibition, ETA + Bi endothelin receptor A and B antagonism, PDE5i phosphodiesterase 5 inhibition, ROSi scavenging of reactive oxygen species